So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

US President Donald Trump on May 23 threatened to impose a 50 percent tariff on all imports from the European Union.

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

Mr. Trump said in remarks to reporters on Monday that pharmaceutical ... tariffs Mr. Trump announced earlier this month and then partly delayed for 90 days. Drugmakers importing from China into ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose ... in place escalating tariffs on imports from China, raising them to 145 percent ...

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

US President Donald Trump’s tariff decisions since he took office on Jan 20 have given investors and political leaders alike ...

Trump and his aides have repeatedly shifted their stance on tariffs in the weeks since the president’s “Liberation Day” ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed ...